COMPASS
    About the CNIC, Research
    CNIC participates in COMPASS, a European project promoting the early detection and personalised treatment of cardiotoxicity in cancer patients

    The initiative will combine innovative medical and digital technologies to improve the early detection of cardiac risk and complications in cancer patients and survivors 

    JACC_Journals
    About the CNIC, Research
    The ACC recognises the research into cardiotoxicity carried out at the CNIC by Danielle Medina-Hernández

    The Young Author Achievement Award recognises her research into cardiotoxicity published in JACC: Cardio-Oncology

    From left to right, Borja Ibáñez, Laura Cádiz, Agustín Clemente Moragón, Ángela Pollán, Lucía López Palomar, and Anabel Díaz Guerra.
    Research, Publications
    Basic Research in Cardiology: A CNIC study shows that the heart can be protected during chemotherapy without reducing antitumor efficacy

    The study shows that a simple, non-pharmacological technique known as remote ischemic conditioning (RIC) can protect the heart during treatment with anthracyclines

    Foto
    Research, Publications
    EHJP: Beta-blockers provide no benefit after myocardial infarction, either in the acute or chronic phase

    A prespecified landmark analysis of the REBOOT trial, published in The European Heart Journal Cardiovascular Pharmacotherapy, shows no clinical benefit of beta-blockers during the first year after infarction or beyond one year, in patients without reduced ejection fraction.

    •  
    • 1 of 11